8-K ·Filed Apr 24, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor upcoming proxy filings for any disclosure of new board appointments or changes in governance structure. Absent unexpected leadership shifts, this event is routine and unlikely to impact trading dynamics.
Final — all horizons settled through T+60d ⚠ clustered
APGE ▲ +55.06% at T+60d
NEUTRAL call ✓ call won +55.06% · α vs SPY +50.28% · entry $86.47 → $134.08
T+1d
-1.27%
call -1.27% · α -0.79%
$85.37
settled 5mo ago
T+5d
-3.38%
call -3.38% · α -3.78%
$83.55
settled 5mo ago
T+20d
-4.23%
call -4.23% · α -9.19%
$82.81
settled 4mo ago
T+60d
+55.06%
call +55.06% · α +50.28%
$134.08
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Apogee Therapeutics announced the resignation of two board members, Andrew Gottesdiener, M.D. and Peter Harwin, effective May 11, 2026. The departures are not due to disagreements with the company, and the board will be reduced from nine to seven members.
Key Facts
- Andrew Gottesdiener, M.D. and Peter Harwin resigned from the board effective May 11, 2026
- Resignations were not due to disagreements with the company
- Board size reduced from nine to seven directors
- No immediate replacements named
Financial Impact
No direct financial impact disclosed
governanceboard composition
Risk Factors
- Potential governance instability if key board committees lose members
- Market perception risk if no replacements are named in a timely manner
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (23 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-177288 |
| Document: 0001193125-26-177288-index-headers.html | 0001193125-26-177288 |
| Document: 0001193125-26-177288-index.html | 0001193125-26-177288 |
| Document: 0001193125-26-177288.txt | 0001193125-26-177288 |
31 reports for APGE
93% Hit rate best @ T+60▲ +73.31%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 15-12G | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | 25-NSE | $135.06 awaiting T+5 | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | 8-K | $135.06 awaiting T+5 | awaiting T+5 | — | — |
Aug 11, 2026 7w ago | 8-K | $134.55 $134.71 | ▲ +0.12% | ▲ +0.56% | — |
Aug 10, 2026 7w ago | 8-K | $134.65 $134.59 | ▼ −0.04% | ▲ +0.00% | — |
Aug 10, 2026 7w ago | Press Release | $134.65 $134.59 | ▼ −0.04% | ▲ +0.00% | — |
Aug 6, 2026 8w ago | Institutional Cluster | $134.49 $134.45 | ▼ −0.03% | ▼ −1.24% | — |
Aug 3, 2026 8w ago | DEFA14A | $134.19 $134.69 | ▲ +0.37% | ▲ +0.47% | — |
Jul 11, 2026 11w ago | Insider Cluster | $133.82 $134.00 | ▲ +0.13% | ▲ +0.92% | — |
Jun 26, 2026 13w ago | DEFA14A | $132.61 $133.50 | ▲ +0.67% | ▼ −0.72% | — |
Showing 10 of 31
US Market Status
Market Open — Closes in 47m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access